Actively Recruiting
Evaluating Safety and Tolerability of Intravenous Difelikefalin in Adolescents Aged 12 to 17 on Haemodialysis with Moderate-to-Severe Itching
Led by Vifor Fresenius Medical Care Renal Pharma · Updated on 2026-10-23
18
Participants Needed
18
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research evaluates the safety and tolerability of intravenous difelikefalin in adolescents aged 12 to 17 years who are on haemodialysis and experience moderate to severe itching related to long-term kidney disease. The study aims primarily to assess safety through monitoring adverse events and secondarily to measure the levels of difelikefalin in the blood. This phase 2, open-label, single-arm study focuses on adolescents with chronic kidney disease with pruritus undergoing regular haemodialysis. Participants will receive difelikefalin intravenously at a dose of 0.5 micrograms per kilogram of dry body weight after each haemodialysis session, three times weekly for up to 12 weeks. The study includes a screening period lasting up to 4 weeks, which contains a 7-day run-in phase, followed by the 12-week treatment period and a safety follow-up visit 7 to 10 days after treatment ends. If difelikefalin treatment is interrupted for more than one week, participants will be withdrawn from the study. During the study, participants will visit the clinic three times weekly coinciding with their haemodialysis sessions over a total duration of up to 17 to 18 weeks. Assessments include monitoring for adverse events, measuring difelikefalin plasma concentrations at selected times, and exploring improvements in itching and quality of life. Safety and tolerability will be closely monitored to evaluate the effects of difelikefalin in this adolescent population.
CONDITIONS
Brief Title
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Research Team
Y
Yael Carmeli
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here